Global expansion Stiplastics is expanding SGH Medical Pharma manufacturing capabilities with a new plant in Tunis, Tunisia, signaling international growth and potential for cross-border plastics and medical device production partnerships.

Medical focus The company operates in medical device and plastic injection components, indicating opportunities to sell sterile plastics, housings, and precision molded parts to healthcare customers and contract manufacturers.

Growth potential Revenue is currently in the sub-million range, suggesting a scalable opportunity through OEM collaborations, co-development programs, and multi-site manufacturing deals to increase capacity and diversify customers.

Digital marketing Active web presence and recent launches (Pilbox site) imply openness to digital sales channels, product showcases, and online lead generation to attract medical and industrial buyers.

Operational readiness With multiple manufacturing plants and a compact team, there is potential to offer flexible sourcing, rapid prototyping, and supplier-diversification services to medical device firms seeking regionalized production.